Discover 867 paid clinical trials in El Paso, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
El Paso offers a variety of clinical research opportunities focused on conditions such as asthma, diabetes, arthritis, and Parkinson’s disease. The city’s growing healthcare sector is actively recruiting participants, providing access to cutting-edge treatments for both healthy volunteers seeking paid research studies and individuals looking for trials targeting specific health conditions.
Filter
2
Filter results
Results: 867
Trial-Ready Cohort-Down Syndrome (TRC-DS)
for
Down Syndrome, Alzheimer Disease, Dementia
Location: Aurora CO, Kansas City KS, Phoenix AZ, St Louis MO,
Sponsor: University of Southern California
Sex: All
Age: 25 - 55
Code: NCT04165109
Recruiting
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
for
Diffuse Cutaneous Systemic Sclerosis
Location: Aurora CO, Allen TX, Dallas TX, Newport Beach CA,
Sponsor: Mediar Therapeutics
Sex: All
Age: 18+
Code: NCT07287670
Phase2, Recruiting
Pulmonary Hypertension Association Registry
for
Pulmonary Arterial Hypertension,
Location: Aurora CO, Salt Lake City UT, Kansas City KS,
Sponsor: Pulmonary Hypertension Association, Inc.
Sex: All
Age: 0+
Code: NCT04071327
Recruiting
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
for
Secondary Progressive Multiple Sclerosis (SPMS)
Location: Aurora CO, Albuquerque NM, Kansas City KS, Phoenix AZ,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT07225504
Phase3, Recruiting
A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
Location: Aurora CO, St Louis MO, Houston TX, Durham NC,
Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Sex: Female
Age: 18+
Code: NCT04516447
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
for
Weight Management
Location: Arvada CO, Ammon ID, Kansas City MO, Tulsa OK,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07667803
Phase3, Recruiting
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
for
Non-small Cell Lung Cancer (NSCLC)
Location: Wheat Ridge CO, Grand Junction CO, Albuquerque NM,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07291037
Phase3, Recruiting
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
for
Prostate Cancer
Location: Lakewood CO, Phoenix AZ, Rochester MN, Austin TX,
Sponsor: AstraZeneca
Sex: Male
Age: 18+
Code: NCT06952803
Phase3, Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
for
Chronic Kidney Disease and Hypertension
Location: Arvada CO, South Salt Lake UT, Hutchinson KS,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06742723
Phase3, Recruiting
A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004
for
Parkinson's Disease
Location: Aurora CO, Tulsa OK, Kansas City KS, Houston TX,
Sponsor: Intec Pharma Ltd.
Sex: All
Age: 30 - 70+
Code: NCT02615873
Phase3, Recruiting
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
for
Parkinsons Disease (PD)
Location: Aurora CO, Kansas City KS, Scottsdale AZ, Sun City AZ,
Sponsor: BlueRock Therapeutics
Sex: All
Age: 45 - 70+
Code: NCT06944522
Phase3, Recruiting
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
for
Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy,
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
for
Breast Cancer, Solid Tumors, Adult
Location: Aurora CO, West Valley City UT, Kansas City MO,